What is Jianmin Pharmaceutical Group Co.,Ltd.'s (600976.SS) StockRank?

MoatMap's StockRank for Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) is 87/100, with a Strong Buy signal. This is a composite score combining Quality (71), Value (63), and Momentum (41) factor ranks across MoatMap's 20,000+ stock universe.

Does Jianmin Pharmaceutical Group Co.,Ltd. have an economic moat?

Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Jianmin Pharmaceutical Group Co.,Ltd. a buy, hold, or sell?

MoatMap's current signal for Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) is Strong Buy, based on a StockRank of 87/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Jianmin Pharmaceutical Group Co.,Ltd. in?

Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

600976.SS

STRONG BUYREMOVE

Jianmin Pharmaceutical Group Co.,Ltd. · Healthcare · China · $690M · Avg Vol: $7M/d

StockRank

P/E (TTM)

11.9x

ROE

12.9%

D/E

0.0x

Dividend %

3.4%

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Jianmin Pharmaceutical focuses on traditional Chinese medicine and pediatric drugs, offering no exposure to the high-moat global CDMO manufacturing cycle.

COMPANY DESCRIPTION

Jianmin Pharmaceutical Group Co.,Ltd. develops, manufactures, and markets traditional Chinese medicines (TCM) and pediatric pharmaceuticals. The company possesses a strong competitive moat through its portfolio of national protected TCM formulas and the highly recognized 'Jianmin' brand. It is a market leader in the pediatric TCM segment, benefiting from long-standing brand heritage and a robust nationwide OTC and hospital sales network.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	538M	623M	518M	498M	-2.5%
EPS	0.40	0.50	0.35	0.35	-4.0%
Shares	153M	153M	153M	153M	0.0%
Debt	8M	17M	26M	19M	33.2%
Equity	275M	332M	360M	393M	12.6%
Op CF	32M	40M	35M	41M	8.3%
Inv CF	-21M	-11M	-36M	-22M	—
Fin CF	-28M	-13M	-15M	-25M	—

PRICE (1M)-16.8%

SMA 50SMA 200

$3.89

RSI (14)

14.4

52W High

$6.29

From 52W High

0.6%

SCORE BREAKDOWN

Quality

ROIC

14.5%83.9

ROE

12.9%78.4

GP/Assets

44.7%82.4

Op. Margin

8.5%62.7

FCF/Assets

3.4%63.7

Piotroski

—83.4

Int. Cover

30.6x79.0

D/E Ratio

0.03x77.5

Current Ratio

1.55x26.3

Value

P/E (TTM)

11.9x83.6

EV/EBITDA

12.0x36.5

P/FCF

203.1x45.4

P/B

1.5x66.6

P/S

1.2x80.3

Div Yield

3.4%76.2

Momentum

52W High %

62%43.9

RS 6M

-35%35.1

SMA 50/200

0.89x31.1

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+106%73.9

Q Growth

-20%24.8

FUNDAMENTALS

Market Cap

$690M

P/E (Forward)

5.8x

Gross Margin

60.2%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 600976.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
600976.SS	Jianmin Pharmaceutical Group Co.,Ltd.(you)	$690M	87	STRONG BUY
002393.SZ	Tianjin Lisheng Pharmaceutical Co.,Ltd.	$679M	90	STRONG BUY
002349.SZ	Jinghua Pharmaceutical Group Co., Ltd.	$866M	85	STRONG BUY
603676.SS	Tibet Weixinkang Medicine Co., Ltd.	$594M	83	STRONG BUY
9989.HK	Shenzhen Hepalink Pharmaceutical Group Co., Ltd.	$773M	93	STRONG BUY
0719.HK	Shandong Xinhua Pharmaceutical Company Limited	$533M	84	STRONG BUY
002737.SZ	Sunflower Pharmaceutical Group Co.,Ltd	$1.1B	88	STRONG BUY
002390.SZ	Guizhou Xinbang Pharmaceutical Co., Ltd.	$870M	81	STRONG BUY
000989.SZ	Jiuzhitang Co., Ltd.	$1.0B	91	STRONG BUY
002332.SZ	Zhejiang Xianju Pharmaceutical Co.,Ltd.	$1.2B	87	STRONG BUY

Peer medians: ROE 4.7% · P/E 27.9x · Gross margin 53.0%

Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) — Stock Score Summary

Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) has a MoatMap StockRank of 87/100 based on Quality (71/100), Value (63/100), and Momentum (41/100) factor scores. The current signal is STRONG BUY. Jianmin Pharmaceutical focuses on traditional Chinese medicine and pediatric drugs, offering no exposure to the high-moat global CDMO manufacturing cycle.

Key Financial Metrics

Price	$3.89
Market Cap	$690M
P/E (TTM)	11.91
P/E (Forward)	5.77
Price/Book	1.48
Return on Equity	12.9%
Return on Invested Capital	14.5%
Debt/Equity	3.46
Gross Margin	60.2%
Operating Margin	8.5%
Revenue Growth	-2.1%
Dividend Yield	3.4%
Free Cash Flow	$3M

Jianmin Pharmaceutical Group Co.,Ltd. operates in the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Jianmin Pharmaceutical Group Co.,Ltd.’s (600976.SS) StockRank?: MoatMap’s StockRank for Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) is 87/100, with a Strong Buy signal. It is a composite of Quality (71), Value (63), and Momentum (41) factor ranks across MoatMap’s 20,000+ stock universe.
Does Jianmin Pharmaceutical Group Co.,Ltd. have an economic moat?: Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) has a Quality factor score of 71/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Jianmin Pharmaceutical Group Co.,Ltd. a buy, hold, or sell?: MoatMap’s current signal for Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) is Strong Buy, based on a StockRank of 87/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Jianmin Pharmaceutical Group Co.,Ltd. in?: Jianmin Pharmaceutical Group Co.,Ltd. (600976.SS) operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry (China).